Wong F, Liu P, Lilly L, Bomzon A, Blendis L
Division of Gastroenterology, The Toronto Hospital, University of Toronto, Toronto, Ontario, Canada.
Clin Sci (Lond). 1999 Sep;97(3):259-67.
The aim of this study was to assess the relationship between subtle cardiovascular abnormalities and abnormal sodium handling in cirrhosis. A total of 35 biopsy-proven patients with cirrhosis with or without ascites and 14 age-matched controls underwent two-dimensional echocardiography and radionuclide angiography for assessment of cardiac volumes, structural changes and systolic and diastolic functions under strict metabolic conditions of a sodium intake of 22 mmol/day. Cardiac output, systemic vascular resistance and pressure/volume relationship (an index of cardiac contractility) were calculated. Eight controls and 14 patients with non-ascitic cirrhosis underwent repeat volume measurements and the pressure/volume relationship was re-evaluated after consuming a diet containing 200 mmol of sodium/day for 7 days. Ascitic cirrhotic patients had significant reductions in (i) cardiac pre-load (end diastolic volume 106+/-9 ml; P<0.05 compared with controls), due to relatively thicker left ventricular wall and septum (P<0.05); (ii) afterload (systemic vascular resistance 992+/-84 dyn.s.cm(-5); P<0. 05 compared with controls) due to systemic arterial vasodilatation; and (iii) reversal of the pressure/volume relationship, indicating contractility dysfunction. Increased cardiac output (6.12+/-0.45 litres/min; P<0.05 compared with controls) was due to a significantly increased heart rate. Pre-ascitic cirrhotic patients had contractile dysfunction, which was accentuated when challenged with a dietary sodium load, associated with renal sodium retention (urinary sodium excretion 162+/-12 mmol/day, compared with 197+/-12 mmol/day in controls; P<0.05). Cardiac output was maintained, since the pre-load was normal or increased, despite a mild degree of ventricular thickening, indicating some diastolic dysfunction. We conclude that: (i) contractile dysfunction is present in cirrhosis and is aggravated by a sodium load; (ii) an increased pre-load in the pre-ascitic patients compensates for the cardiac dysfunction; and (iii) in ascitic patients, a reduced afterload, manifested as systemic arterial vasodilatation, compensates for a reduced pre-load and contractile dysfunction. Cirrhotic cardiomyopathy may well play a pathogenic role in the complications of cirrhosis.
本研究旨在评估肝硬化患者细微心血管异常与钠代谢异常之间的关系。共有35例经活检证实的肝硬化患者(有或无腹水)以及14例年龄匹配的对照者,在每日摄入22 mmol钠的严格代谢条件下,接受二维超声心动图和放射性核素血管造影检查,以评估心脏容积、结构变化以及收缩和舒张功能。计算心输出量、全身血管阻力和压力/容积关系(心脏收缩力指标)。8例对照者和14例无腹水肝硬化患者在摄入含200 mmol钠/天的饮食7天后,再次进行容积测量并重新评估压力/容积关系。腹水型肝硬化患者存在以下显著降低情况:(i)心脏前负荷(舒张末期容积106±9 ml;与对照者相比P<0.05),原因是左心室壁和室间隔相对增厚(P<0.05);(ii)后负荷(全身血管阻力992±84 dyn.s.cm⁻⁵;与对照者相比P<0.05),原因是全身动脉血管扩张;(iii)压力/容积关系逆转,表明收缩功能障碍。心输出量增加(6.12±0.45升/分钟;与对照者相比P<0.05)是由于心率显著增加。腹水前期肝硬化患者存在收缩功能障碍,在接受饮食钠负荷刺激时会加重,同时伴有肾钠潴留(尿钠排泄162±12 mmol/天,对照者为197±12 mmol/天;P<0.05)。尽管心室轻度增厚表明存在一定程度的舒张功能障碍,但由于前负荷正常或增加,心输出量得以维持。我们得出以下结论:(i)肝硬化患者存在收缩功能障碍,且钠负荷会使其加重;(ii)腹水前期患者前负荷增加可代偿心脏功能障碍;(iii)腹水患者后负荷降低,表现为全身动脉血管扩张,可代偿前负荷降低和收缩功能障碍。肝硬化性心肌病很可能在肝硬化并发症中起致病作用。